Skip to content

Palbociclib

Generic Medicine With 6 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Palbociclib

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Endocrine Disorders Palbociclib is a kinase inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: An aromatase inhibitor as initial endocrine-based therapy in postmenopausal women; or Fulvestrant in women with disease progression following endocrine therapy.

Dosage And Administration

The recommended dose of Palbociclib is a 125 mg capsule taken orally once daily for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days. Palbociclib should be taken with food. Patients should be encouraged to take their dose of Palbociclib at approximately the same time each day. For men treated with combination Palbociclib plus aromatase inhibitor therapy, consider treatment with an LHRH agonist according to current clinical practice standards. Recommended Dose Modification for Adverse Reactions: Recommended Starting Dose: 125 mg/day First Dose Reduction: 100 mg/day Second Dose Reduction: 75 mg/day If further dose reduction below 75 mg/day is required, discontinue. Or, as directed by the registered physician. Use in Children: Palbociclib is not indicated for use in children.

Side Effects

Common side effects of Palbociclib include: WBC decreased, Neutrophils decreased, Neutropenia, Platelets decreased, infections, AST increased, ALT increased, Leukopenia, Fatigue, Nausea, Hair loss, Inflammation of the mouth and lips, Diarrhea, Anemia, Rash, Weakness/lethargy, Vomiting, Thrombocytopenia, Dry skin, Fever.

Precautions And Warnings

Neutropenia: Neutropenia was the most frequently reported adverse reaction. Monitor complete blood counts prior to starting Palbociclib therapy and at the beginning of each cycle, as well as on day 15 of the first 2 cycles, and as clinically indicated. Dose interruption, dose reduction, or delay in starting treatment cycles is recommended for patients who develop grade 3 or 4 neutropenia. Febrile neutropenia has been reported in 1.8% of patients exposed to Palbociclib. One death due to neutropenic sepsis was observed. Physicians should inform patients to promptly report any episodes of fever. Embryo-Fetal Toxicity: Palbociclib can cause fetal harm when administered to a pregnant woman. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Palbociclib and for at least 3 weeks after the last dose.

Pregnancy And Lactation

Palbociclib can cause fetal harm when administered to a pregnant woman. Advise pregnant women of the potential risk to a fetus. Risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%-4% and 15%-20%, respectively.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 6

Sorted By
Capsule

Cykin 125 mg

Generic: Palbociclib

2600.00Taka / Unit

View Medicine
Capsule

Palbo 125 mg

Generic: Palbociclib

400.00Taka / Unit

View Medicine
Capsule

Palbocent 125 mg

Generic: Palbociclib

400.00Taka / Unit

View Medicine
Capsule

Palboxen 125 mg

Generic: Palbociclib

400.00Taka / Unit

View Medicine
Capsule

Palcigen 125 mg

Generic: Palbociclib

400.00Taka / Unit

View Medicine
Capsule

Palker 125 mg

Generic: Palbociclib

400.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250